Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

GlaxoSmithKline PLC (NYSE:GSK)

39.24
Delayed Data
As of Aug 16
 +0.29 / +0.74%
Today’s Change
37.20
Today|||52-Week Range
44.59
+1.90%
Year-to-Date
Orleans Capital Management Corp Buys SPDR Select Sector Fund - Consumer Discretionary...
Aug 15 / GuruFocus News - Paid Partner Content
Mylan Badly Needs Help from FDA to Escape its Woes and Deliver These Key Drugs
Aug 11 / TheStreet.com - Paid Partner Content
Shire Gains as it Seeks European Approval For Dry Eye Treatment
Aug 15 / TheStreet.com - Paid Partner Content
The Stock Market Is Still Tanking Thanks to North Korea Tensions
Aug 10 / TheStreet.com - Paid Partner Content
Ionis Pharmaceuticals Retains Rights to Inotersen, Stock Up
Aug 14 / Zacks.com - Paid Partner Content
Mylan (MYL) Misses on Q2 Earnings & Sales, Lowers View
Aug 09 / Zacks.com - Paid Partner Content
Stocks That Fell to 3-Year Lows in the Week of August 11
Aug 13 / GuruFocus News - Paid Partner Content